PRELIMINARY-ANALYSIS OF CLINICAL CHARACTERISTICS OF PATIENTS ENROLLED IN THE HD01 PROTOCOL - A RANDOMIZED TRIAL OF HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION VERSUS CONVENTIONAL THERAPY FOR PATIENTS WITH ADVANCED HODGKINS-DISEASE RESPONDING TO FIRST-LINE THERAPY

[1] Kaplan H.S., Hodgkin's disease. Unfolding concepts concerning its nature, management and prognosis, Cancer, 45, pp. 2439-2474, (1979)

[2] De Vita V.T., Hubbard S.M., Longo D.L., The chemotherapy of lymphomas: looking back, moving forward. The Richard and Hinda Rosenthal Foundation Award Lecture, Cancer Res., 47, pp. 5810-5824, (1987)

[3] Bonadonna G., Zucali R., Monfardini S., Et al., Combination chemotherapy of Hodgkin's disease with Adriamycin, Bleomycin, Vinblastine and Imidazole carboximide versus MOPP, Cancer, 36, pp. 252-259, (1975)

[4] Canellos G., Anderson J.R., Propert K.J., Et al., Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD, New Engl. J. Med., 327, pp. 1478-1484, (1992)

[5] Gobbi P.G., Pieresca C., Federico M., Et al., MOPP/EBV/CAD hybrid chemotherapy ± limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group (GISL), J. Clin. Oncol., 11, pp. 712-719, (1993)

[6] Klimo P., Connors J.M., An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program, Semin. Hematol., 25, pp. 34-40, (1988)

[7] Urba W.J., Longo D.L., Hodgkin's disease, New Engl. J. Med., 326, pp. 678-687, (1992)

[8] Carella A.M., Congiu A.M., Gaozza E., Et al., High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report, J. Clin. Oncol., 6, pp. 1411-1416, (1988)

[9] Philip T., Dumont J., Teillet F., Et al., High-dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease, Brit. J. Cancer, 53, pp. 737-742, (1986)

[10] Gribben J.G., Linch D.C., Singer C.R.J., Et al., Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation, Blood, 73, pp. 340-344, (1989)

[1] Kaplan H.S., Hodgkin's disease. Unfolding concepts concerning its nature, management and prognosis, Cancer, 45, pp. 2439-2474, (1979)

[2] De Vita V.T., Hubbard S.M., Longo D.L., The chemotherapy of lymphomas: looking back, moving forward. The Richard and Hinda Rosenthal Foundation Award Lecture, Cancer Res., 47, pp. 5810-5824, (1987)

[3] Bonadonna G., Zucali R., Monfardini S., Et al., Combination chemotherapy of Hodgkin's disease with Adriamycin, Bleomycin, Vinblastine and Imidazole carboximide versus MOPP, Cancer, 36, pp. 252-259, (1975)

[4] Canellos G., Anderson J.R., Propert K.J., Et al., Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD, New Engl. J. Med., 327, pp. 1478-1484, (1992)

[5] Gobbi P.G., Pieresca C., Federico M., Et al., MOPP/EBV/CAD hybrid chemotherapy ± limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group (GISL), J. Clin. Oncol., 11, pp. 712-719, (1993)

[6] Klimo P., Connors J.M., An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program, Semin. Hematol., 25, pp. 34-40, (1988)

[7] Urba W.J., Longo D.L., Hodgkin's disease, New Engl. J. Med., 326, pp. 678-687, (1992)

[8] Carella A.M., Congiu A.M., Gaozza E., Et al., High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report, J. Clin. Oncol., 6, pp. 1411-1416, (1988)

[9] Philip T., Dumont J., Teillet F., Et al., High-dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease, Brit. J. Cancer, 53, pp. 737-742, (1986)

[10] Gribben J.G., Linch D.C., Singer C.R.J., Et al., Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation, Blood, 73, pp. 340-344, (1989)